Results of clinical trials of Magnevist, a new contrast medium for magnetic resonance tomography, are presented. Magnevist application ensures the best imaging of brain and spinal cord tumors and favours the differential diagnosis.

Original languageEnglish
Pages (from-to)22-25
Number of pages4
JournalVestnik Rentgenologii i Radiologii
Issue number4
StatePublished - Jul 1994

    Scopus subject areas

  • Medicine(all)

ID: 75566145